The transgenic construct contained a Msmb promoter/enhancer fragment, extending from -3842 through +16, adjoined to sequence encoding the SV40 large and small T antigens. The Msmb promoter/enhancer fragment drove expression in the ventral and dorsolateral prostate lobes.